FDA Approves SPEVIGO for Generalized Pustular Psoriasis Flares
Physician’s Briefing Staff
TUESDAY, Sept. 6, 2022 (HealthDay News) -- The U.S. Food and Drug Administration has approved SPEVIGO (spesolimab-sbzo) as…
Browsing Tag
Generalized
Zai Lab Announces Acceptance by China’s NMPA of the BLA for Efgartigimod for Patients…
SHANGHAI and SAN FRANCISCO and CAMBRIDGE, Mass., July 13, 2022 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), a patient-focused, innovative, commercial-stage, global…
Dramatic Improvement in Generalized Pustular Psoriasis With IL-36 Inhibitor
Patients with severe generalized pustular psoriasis (GPP) had rapid clearance of skin lesions…
ADHD can Lead to Generalized Anxiety Disorder in Adults
"These findings underline how vulnerable adults with ADHD are to generalized anxiety disorders," says lead author Esme Fuller-Thomson, professor at the University of Toronto's…
NeuroPace Receives IDE Approval to Initiate NAUTILUS Pivotal Study of its RNS System…
IDE study will be first to evaluate the effectiveness of brain-responsive neuromodulation to treat primary generalized epilepsy in patients aged 12 and older MOUNTAIN VIEW, Calif., Nov.…
AnaptysBio Presents Updated Data From Imsidolimab Phase 2 GALLOP Trial in Generalized…
Imsidolimab demonstrated rapid and sustained efficacy with 6 of 8 (75%) generalized pustular psoriasis (GPP) patients achieving the primary endpoint at week 4 and week 16Early reduction of…